Argenica Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:AGN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Jul 24	BuyAU$2,276,257	MLC Investments Limited	Company	4,382,545	AU$0.80
01 Jul 24	SellAU$38,548	IOOF Investment Management Limited	Company	65,727	AU$0.59
24 Jun 24	BuyAU$1,272,017	IOOF Investment Management Limited	Company	1,957,632	AU$0.84

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AGN?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	4,425,161	3.45%
Institutions	29,366,098	22.9%
Individual Insiders	32,138,549	25.1%
General Public	62,163,037	48.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.2%.

Top Shareholders

Top 25 shareholders own 51.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.4%	Ak Portföy Yönetimi AS	9,475,381	AU$5.7m	0%	0.14%
5.78%	Neil Delroy	7,405,976	AU$4.5m	57.5%	no data
4.54%	Euroz Hartleys Group Limited, Asset Management Arm	5,814,891	AU$3.5m	0%	no data
3.69%	Geoffrey Richard Pocock	4,730,929	AU$2.9m	0%	no data
3.42%	MLC Investments Limited	4,382,545	AU$2.7m	0%	0.61%
2.77%	Perron Institute For Neurological And Translational Science, Endownment Arm	3,550,000	AU$2.1m	0%	no data
2.34%	James Litis	2,992,308	AU$1.8m	6.87%	no data
2.24%	The University of Western Australia, Endowment Arm	2,868,876	AU$1.7m	-16.1%	33.69%
1.67%	AGATI PTY LTD	2,133,083	AU$1.3m	592%	no data
1.56%	Samantha South	2,000,000	AU$1.2m	0%	no data
1.56%	Shane Colley	2,000,000	AU$1.2m	0%	no data
1.48%	IOOF Investment Management Limited	1,891,905	AU$1.1m	0%	0.03%
1.3%	Helen Sewell	1,662,500	AU$1.0m	0%	no data
1.28%	Liz Dallimore	1,640,909	AU$992.7k	3,180%	no data
1.21%	Ian Middlemas	1,550,000	AU$937.8k	0%	no data
1.21%	Gary Wayne	1,545,952	AU$935.3k	0%	no data
1.08%	Xcel Capital Pty Ltd, Asset Mangement Arm	1,382,500	AU$836.4k	-5.47%	60.54%
1.05%	Emma Waldon	1,343,182	AU$812.6k	31%	no data
0.98%	Bruno Meloni	1,252,000	AU$757.5k	-1.96%	no data
0.93%	Pindan Investments Pty. Ltd.	1,185,332	AU$717.1k	24%	no data
0.86%	Oeneus Pty Ltd	1,106,746	AU$669.6k	7.83%	no data
0.86%	Shane Wee	1,100,000	AU$665.5k	-32.5%	no data
0.64%	Elizabeth Dawson	820,455	AU$496.4k	0%	no data
0.64%	Lewis Dawson	820,454	AU$496.4k	0%	no data
0.63%	Terence Budge	805,702	AU$487.5k	65.3%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 06:39
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Argenica Therapeutics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution